Published in
Esmo Open, Esmo Open, 4(7), p. 100530, 2022
DOI: 10.1016/j.esmoop.2022.100530
Links
Tools
Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors
Journal article published in 2022 by
E. Borazanci,
A. M. Schram,
E. Garralda 
,
I. Brana,
M. Vieito Villar,
A. Spreafico,
M. Oliva,
N. J. Lakhani,
K. Hoffman,
R. M. Hallett,
D. Maetzel,
F. Hua,
J. Hilbert,
P. Giblin,
J. Anido
and other authors.
,
I. Brana,
M. Vieito Villar,
A. Spreafico,
M. Oliva,
N. J. Lakhani,
K. Hoffman,
R. M. Hallett,
D. Maetzel,
F. Hua,
J. Hilbert,
P. Giblin,
J. Anido
and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Data provided by 